drugset

drugset / Trial / NCT05269134

Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

NCT05269134 ↗

Phase 2 Withdrawn Adaptive Phage Therapeutics, Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a study designed to evaluate bacteriophage therapy in patients with chronic prosthetic joint infections.

Timeline

Start: 2023-03-27
Primary completion: 2025-07
Completion: 2027-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bacteriophage	Other / unclassified	—	—

Indications